CoLabs Int’l Corp.
(Note: CoLabs Int’l Corp. withdrew its IPO plans in an SEC filing dated Jan. 30, 2024. The company filed its S-1 on March 27, 2023.) CoLabs Int’l Corp. is an over-the-counter (“OTC”) pharmaceutical company with multi-market applications for our revolutionary targeted drug delivery system which is identified as QuantaSphere® Technology (QS®). (Incorporated in Nevada) We currently […]
April 1, 2023 Read More